BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11518020)

  • 1. Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).
    Damian F; Blaton N; Desseyn H; Clou K; Augustijns P; Naesens L; Balzarini J; Kinget R; Van den Mooter G
    J Pharm Pharmacol; 2001 Aug; 53(8):1109-16. PubMed ID: 11518020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.
    Damian F; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Sep; 244(1-2):87-98. PubMed ID: 12204568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.
    Martínez-Ohárriz MC; Rodríguez-Espinosa C; Martín C; Goñi MM; Tros-Ilarduya MC; Sánchez M
    Drug Dev Ind Pharm; 2002 Jul; 28(6):717-25. PubMed ID: 12149965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
    Tantishaiyakul V; Kaewnopparat N; Ingkatawornwong S
    Int J Pharm; 1999 Apr; 181(2):143-51. PubMed ID: 10370210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
    Huang BB; Liu DX; Liu K; Wu G
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
    Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
    Goddeeris C; Willems T; Van den Mooter G
    Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state.
    Tobyn M; Brown J; Dennis AB; Fakes M; Gao Q; Gamble J; Khimyak YZ; McGeorge G; Patel C; Sinclair W; Timmins P; Yin S
    J Pharm Sci; 2009 Sep; 98(9):3456-68. PubMed ID: 19603506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X; Xu T; Huang W; Fan B; Sheng X
    AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of bicalutamide solid dispersions and improvement of the dissolution.
    Ren F; Jing Q; Tang Y; Shen Y; Chen J; Gao F; Cui J
    Drug Dev Ind Pharm; 2006 Sep; 32(8):967-72. PubMed ID: 16954109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.